Nonmuscle Invasive Bladder Cancer clinical trials

Explore recruiting nonmuscle invasive bladder cancer clinical trials.

Recruiting nonmuscle invasive bladder cancer studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Nonmuscle Invasive Bladder Cancer trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 3, Single-arm, Multicenter Study to Evaluate the Efficacy and Safety of UGN-103, a Novel Formulation of UGN-102, for the Treatment of Patients With Low Grade (LG) Nonmuscle Invasive Bladder Cancer (NMIBC) at Intermediate Risk (IR) of Recurrence (UTOPIA)

Romania, Spain, Bulgaria, Latvia, Estonia

Therapeutic confirmatory (Phase III) EU CTIS Study details

Nonmuscle Invasive Bladder Cancer trials by city

Nonmuscle Invasive Bladder Cancer in Toronto Nonmuscle Invasive Bladder Cancer in Vancouver Nonmuscle Invasive Bladder Cancer in Montreal Nonmuscle Invasive Bladder Cancer in Calgary Nonmuscle Invasive Bladder Cancer in Edmonton Nonmuscle Invasive Bladder Cancer in Ottawa Nonmuscle Invasive Bladder Cancer in Winnipeg Nonmuscle Invasive Bladder Cancer in Quebec City Nonmuscle Invasive Bladder Cancer in Hamilton Nonmuscle Invasive Bladder Cancer in Kitchener Nonmuscle Invasive Bladder Cancer in London Nonmuscle Invasive Bladder Cancer in Halifax Nonmuscle Invasive Bladder Cancer in New York Nonmuscle Invasive Bladder Cancer in Los Angeles Nonmuscle Invasive Bladder Cancer in Chicago Nonmuscle Invasive Bladder Cancer in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease